Form 4 for GENB Generate Biomedicines, Inc.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0001193125-26-096799 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | 2026-03-04 | GENB | Nally Michael | CEO, Dir | P - Purchase | $12.00 | +20.0K | 572.7K | +4% | +$240.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | P | A | 20,000 | $12.00 | 572,707 | D | — | — |